Changes in angiogenesis markers during neoadjuvant treatment for locally advanced breast cancer
The impact of various neoadjuvant treatment regimens on the level of enzyme immunoassay-determined angiogenic markers of endothelial growth factor and its type 2 receptor in tumor cytosol and serum was assessed in 30 patients with locally advanced breast cancer (BC). The findings suggest the promise...
Main Authors: | E. A. Kim, I. V. Vysotskaya, N. E. Kushlinsky, V. P. Letyagin, E. S. Gershtein |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-08-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/210 |
Similar Items
-
The immunohistochemical landscape of the VEGF family and its receptors in glioblastomas
by: Luiz Victor Maia Loureiro, et al.
Published: (2020-03-01) -
Immunohistological study of the effect of vascular Endothelial Growth Factor on the angiogenesis of mature root canals in rat molars
by: Cleber Keiti Nabeshima, et al.
Published: (2018-05-01) -
Role of tumour angiogenesis in haematological malignancies
by: Michael Medinger, et al.
Published: (2014-11-01) -
Various doses of statins and coronary angiogenesis in patients with coronary heart disease
by: I. V. Sergienko, et al.
Published: (2009-10-01) -
Evaluation of Angiogenesis Assays
by: Zachary I. Stryker, et al.
Published: (2019-05-01)